JP Morgan Reiterates Overweight on NVIDIA, $320 Price Target
- Rating
- Overweight
- Unchanged
- Target
- $320
- Unchanged
- Upside
- +71%
- NVDA at $187 today

What the analyst said
JPMorgan analyst Harlan Sur reiterated an Overweight rating and $320 price target on NVIDIA (NASDAQ: NVDA).
“Yesterday, we held a virtual NDR for investors, during which we spoke with Toshiya Hari, Vice President of Investor Relations & Strategic Finance at NVIDIA Corporation (NVDA). Mr.
Hari indicated that the 70% Y/Y growth framework for FY28 was not driven by any single factor, but rather by continued strength across the market, including hyperscalers, neoclouds, AI labs, sovereign AI, and enterprise/on-prem demand.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
NVDA trades at $187. The 27 analysts who set a target in the last 3 months range from $270 to $515, with a median of $315. This $320 target is 2% above the median.
Since the note NVDA has moved −14% (from $217). 12-month window: day 65 of 365, closes on September 2, 2027.
Track record
This callOpen: NVDA has not reached $320 yet. This 12-month target is scored on August 27, 2027. Same target as this firm’s August 27, 2026 note, so it is scored there.
Firm track recordJP Morgan: 64% of its 28 targets at least a year old were reached within 12 months (#22 of 26 firms); on NVIDIA, 3 of 3. Accuracy ranking →
JP Morgan on NVIDIA
JP Morgan price targets on NVIDIA
6 calls from August 28, 2025 to September 2, 2026. The target went from $215 to $320 (+49%). The rating stayed Buy.



